{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:22:49Z","timestamp":1789636969052,"version":"4.0.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Law and the BioSci"],"published-print":{"date-parts":[[2016,12,1]]},"DOI":"10.1093\/jlb\/lsw046","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T03:08:54Z","timestamp":1474081734000},"page":"489-537","source":"Crossref","is-referenced-by-count":29,"title":["EBOLA and FDA: reviewing the response to the 2014 outbreak, to find lessons for the future"],"prefix":"10.1093","volume":"3","author":[{"given":"Emily A.","family":"Largent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,9,16]]},"container-title":["Journal of Law and the Biosciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jlb\/article-pdf\/3\/3\/489\/17699183\/lsw046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T01:56:00Z","timestamp":1503626160000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jlb\/article-lookup\/doi\/10.1093\/jlb\/lsw046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,12,27]]},"published-print":{"date-parts":[[2016,12,1]]}},"alternative-id":["10.1093\/jlb\/lsw046"],"URL":"https:\/\/doi.org\/10.1093\/jlb\/lsw046","relation":{},"ISSN":["2053-9711"],"issn-type":[{"value":"2053-9711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,16]]}}}